The Uromigos
Advertisement
Dr. Gerhardt Attard discusses practice-changing data from AMPLITUDE, and the history of PARP inhibitor use.
Dr. Nick James discusses data from STAMPEDE on the use of AI to predict benefit from ADT + abiraterone.
Dr. Jorge Garcia discusses the process of selecting abstracts for oral presentation.
Dr. Toni Choueiri discusses this combination cohort of HIF inhibition plus VEGF-R inhibition.
Dr. Matt Galsky discusses the 2025 ASCO Annual Meeting data regarding ctDNA from the NIAGARA study.
Dr. Jeannie Hoffman-Censits discusses her randomized phase 2 trial on adding sacituzumab govitecan to maintenance avelumab.
Dr. Michiel Van Der Heijden joins the podcast to discuss his trial on ipilimumab + nivolumab vs chemotherapy randomization.
Dr. Monty Pal discusses more correlative data from the IMmotion010 trial, including matched baseline samples.
Dr. McDermott recaps his discussion on biomarkers in kidney cancer from the 2025 ASCO Annual Meeting.
Returning guest Silke Gillessen joins the show to chat with Tom and Brian on what they are looking forward to at ASCO 2025.
Returning guests Drs. Gillessen and Sweeney discuss the value of treatments for advanced prostate cancer.
Dr. Joe Jacob joins the show to discuss the longer-term follow up of this cohort from SunRISe-1.
Dr. Viktor Grünwald joins the show to discuss the new data session from the European International Kidney Cancer Symposium.
Dr. Mark Tyson from Mayo Clinic joins the podcast to discuss the high CR rate seen in cohort C of the BOND-003 trial.
Dr. Neal Shore joins the show to discuss exciting data from the CREST trial.
Part 2 dives deeper into the explosion of ADC clinical drug development in China.
Drs. Dingwei Ye and Yao Zhu join the show to discuss drug development in China amid the recent surge of GU clinical trials.
Drs. Alicia Morgans and Chuck Ryan join the show to discuss their new podcast.
Dr. Elena Castro of Virgen de la Victoria University Hospital in Malaga, Spain joins Tom and Brian to discuss PSMAFore data.
Dr. Ignacio Duran continues his discussion with Brian and Tom regarding novel ADCS in bladder cancer.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.